Dompé Farmaceutici S.p.A | ClinicalTrials HQ

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED	Conjunctival Diseases, Conjunctivitis, Allergic, Hypersensitivity, Immediate, conjunctivitis, eye disorder, immune system disorder	Recruiting	Phase 3	2026-10-07		NCT07519902
An Efficacy and Safety Study of DFL24498 in the Treatment of AKC	Bronchiolitis Obliterans, atopic keratoconjunctivitis, bronchial disorder, bronchiolitis, bronchiolitis obliterans syndrome, bronchitis, cryptogenic organizing pneumonia, graft versus host disease, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder	Recruiting	Phase 3	2026-09-21		NCT07395232
Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)	Optic Neuropathy, Ischemic, cardiovascular disorder, cranial nerve neuropathy, eye disorder, nervous system disorder, non-arteritic anterior ischemic optic neuropathy, optic nerve disorder, vascular disorder	Recruiting	Phase 3	2026-09-10		NCT07453888
An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease	Conjunctival Diseases, dry eye syndrome, eye disorder, lacrimal apparatus disorder, xerophthalmia	Recruiting	Phase 2	2026-06-26		NCT07503886
Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)	Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis	Recruiting	Phase 2	2026-05-06		NCT05835466